Dadi Jiang

2.7k total citations
34 papers, 1.9k citations indexed

About

Dadi Jiang is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Dadi Jiang has authored 34 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Cell Biology. Recurrent topics in Dadi Jiang's work include Endoplasmic Reticulum Stress and Disease (7 papers), Cancer-related Molecular Pathways (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Dadi Jiang is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (7 papers), Cancer-related Molecular Pathways (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Dadi Jiang collaborates with scholars based in United States, United Kingdom and New Zealand. Dadi Jiang's co-authors include Laura D. Attardi, Colleen A. Brady, Albert C. Koong, Daniela Kenzelmann Brož, Stephano S. Mello, Rachel L. Dusek, Kathryn T. Bieging, Maho Niwa, Thomas M. Johnson and Amato J. Giaccia and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Dadi Jiang

33 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dadi Jiang United States 18 1.1k 784 411 377 311 34 1.9k
Gianluca Bossi Italy 30 1.4k 1.2× 988 1.3× 254 0.6× 547 1.5× 209 0.7× 53 2.2k
Sandy Giuliano France 23 1.4k 1.3× 656 0.8× 335 0.8× 554 1.5× 223 0.7× 29 2.1k
Meike Vogler Germany 26 2.1k 1.9× 769 1.0× 563 1.4× 362 1.0× 224 0.7× 59 2.9k
Mingjia Tan United States 31 1.9k 1.7× 760 1.0× 312 0.8× 434 1.2× 310 1.0× 46 2.5k
Dayana B. Rivadeneira United States 17 1.1k 1.0× 957 1.2× 802 2.0× 714 1.9× 238 0.8× 26 2.3k
Song He China 30 1.5k 1.4× 586 0.7× 252 0.6× 593 1.6× 236 0.8× 93 2.1k
Jinyang Li United States 25 1.3k 1.2× 985 1.3× 470 1.1× 610 1.6× 137 0.4× 51 2.4k
Eunice Y. Lau Hong Kong 20 1.1k 1.0× 624 0.8× 397 1.0× 755 2.0× 145 0.5× 37 2.0k
Rongxin Chen China 29 802 0.7× 760 1.0× 357 0.9× 592 1.6× 362 1.2× 114 2.5k
Géraldine Gentric France 13 951 0.9× 752 1.0× 408 1.0× 602 1.6× 163 0.5× 17 1.8k

Countries citing papers authored by Dadi Jiang

Since Specialization
Citations

This map shows the geographic impact of Dadi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dadi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dadi Jiang more than expected).

Fields of papers citing papers by Dadi Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dadi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dadi Jiang. The network helps show where Dadi Jiang may publish in the future.

Co-authorship network of co-authors of Dadi Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Dadi Jiang. A scholar is included among the top collaborators of Dadi Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dadi Jiang. Dadi Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Dadi, Li Zhuang, Albert C. Koong, & Boyi Gan. (2025). Cuproptosis in cancer: from molecular mechanisms to therapeutic intervention. Trends in cancer. 12(3). 275–286.
2.
Mao, Chao, Dadi Jiang, Albert C. Koong, & Boyi Gan. (2025). Exploiting metabolic cell death for cancer therapy. Nature reviews. Cancer. 26(1). 27–45. 3 indexed citations
3.
Wang, Tianyu, Liang Wang, Youming Guo, et al.. (2025). Abstract B032: Concurrent mutant KRAS inhibition and Stereotactic Body Radiation Therapy (SBRT) for preclinical KRASG12D-Driven Pancreatic Ductal Adenocarcinoma (PDAC) treatment. Clinical Cancer Research. 31(2_Supplement). B032–B032. 1 indexed citations
4.
Guan, Fada, Dadi Jiang, Xiaochun Wang, et al.. (2024). Mimicking large spot‐scanning radiation fields for proton FLASH preclinical studies with a robotic motion platform. SHILAP Revista de lepidopterología. 8(4). 168–181. 1 indexed citations
5.
Jiang, Dadi, Youming Guo, Tianyu Wang, et al.. (2024). IRE1α determines ferroptosis sensitivity through regulation of glutathione synthesis. Nature Communications. 15(1). 4114–4114. 22 indexed citations
6.
Feng, Xu, Mengfan Tang, Merve Dede, et al.. (2022). Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors. Science Advances. 8(19). eabm6638–eabm6638. 25 indexed citations
7.
Miao, Yu Rebecca, Kaushik N. Thakkar, Can Cenik, et al.. (2022). Developing high-affinity decoy receptors to treat multiple myeloma and diffuse large B cell lymphoma. The Journal of Experimental Medicine. 219(9). 6 indexed citations
8.
Yang, Ming, Xiaochun Wang, Fada Guan, et al.. (2022). Adaptation and dosimetric commissioning of a synchrotron-based proton beamline for FLASH experiments. Physics in Medicine and Biology. 67(16). 165002–165002. 12 indexed citations
9.
Aguilera, Todd A., Eslam A. Elghonaimy, Hussein Shehade, et al.. (2020). Induced Tumor Heterogeneity Reveals Factors Informing Radiation and Immunotherapy Combinations. Clinical Cancer Research. 26(12). 2972–2985. 6 indexed citations
10.
Yang, Zhifen, Jing Zhang, Dadi Jiang, et al.. (2018). A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α–XBP1 Activation. Molecular Cancer Research. 16(5). 745–753. 9 indexed citations
11.
Jiang, Dadi, Arvin B. Tam, Muthuraman Alagappan, et al.. (2016). Acridine Derivatives as Inhibitors of the IRE1α–XBP1 Pathway Are Cytotoxic to Human Multiple Myeloma. Molecular Cancer Therapeutics. 15(9). 2055–2065. 27 indexed citations
12.
Jiang, Dadi, Connor Lynch, Bruno C. Medeiros, et al.. (2016). Identification of Doxorubicin as an Inhibitor of the IRE1α-XBP1 Axis of the Unfolded Protein Response. Scientific Reports. 6(1). 33353–33353. 29 indexed citations
13.
Aguilera, Todd A., Marjan Rafat, Laura Castellini, et al.. (2016). Reprogramming the immunological microenvironment through radiation and targeting Axl. Nature Communications. 7(1). 13898–13898. 140 indexed citations
14.
Alagappan, Muthuraman, Dadi Jiang, Nicholas Denko, & Albert C. Koong. (2016). A Multimodal Data Analysis Approach for Targeted Drug Discovery Involving Topological Data Analysis (TDA). Advances in experimental medicine and biology. 899. 253–268. 6 indexed citations
15.
Jiang, Dadi, Edward L. LaGory, Daniela Kenzelmann Brož, et al.. (2015). Analysis of p53 Transactivation Domain Mutants Reveals Acad11 as a Metabolic Target Important for p53 Pro-Survival Function. Cell Reports. 10(7). 1096–1109. 54 indexed citations
16.
Jiang, Dadi & Laura D. Attardi. (2013). Engaging the p53 metabolic brake drives senescence. Cell Research. 23(6). 739–740. 11 indexed citations
17.
Brož, Daniela Kenzelmann, Stephano S. Mello, Kathryn T. Bieging, et al.. (2013). Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses. Genes & Development. 27(9). 1016–1031. 345 indexed citations
18.
Brady, Colleen A., Dadi Jiang, Stephano S. Mello, et al.. (2011). Distinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression. Cell. 145(4). 571–583. 422 indexed citations
19.
Jiang, Dadi, Colleen A. Brady, Thomas M. Johnson, et al.. (2011). Full p53 transcriptional activation potential is dispensable for tumor suppression in diverse lineages. Proceedings of the National Academy of Sciences. 108(41). 17123–17128. 68 indexed citations
20.
Beaudry, Veronica G., Dadi Jiang, Rachel L. Dusek, et al.. (2010). Loss of the p53/p63 Regulated Desmosomal Protein Perp Promotes Tumorigenesis. PLoS Genetics. 6(10). e1001168–e1001168. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gianluca Bossi Breakdown of academic impact, for papers by Sandy Giuliano Breakdown of academic impact, for papers by Meike Vogler Breakdown of academic impact, for papers by Mingjia Tan Breakdown of academic impact, for papers by Dayana B. Rivadeneira Breakdown of academic impact, for papers by Song He Breakdown of academic impact, for papers by Jinyang Li Breakdown of academic impact, for papers by Eunice Y. Lau Breakdown of academic impact, for papers by Rongxin Chen Breakdown of academic impact, for papers by Géraldine Gentric
Rankless by CCL
2026